Clinical Trial: Guanfacine and Cromolyn Sodium for POTS: The DBPOTS Trial

U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07757555) titled 'Guanfacine and Cromolyn Sodium for POTS: The DBPOTS Trial' on Aug. 06.

Brief Summary: The goal of this clinical trial is to learn whether guanfacine or cromolyn sodium can improve symptoms and physical functioning in adults with Postural Orthostatic Tachycardia Syndrome (POTS). Both medications are FDA-approved for other conditions but are investigational for the treatment of POTS.

The main questions this study aims to answer are:

Does treatment with guanfacine or cromolyn sodium improve physical functioning in adults with POTS compared with placebo? Does treatment with guanfacine or cromolyn sodium improve fatigue, cognitive func...